Investigating the growth trend of biomedical production in Iran and futurology to achieve the horizon of 1404
Abstract
Background Biomedical drugs have been considered by many countries due to their important effect and high value. In the upstream documents, achieving a share of 3% of the global market of these drugs is set for 1404.The purpose of this study is to calculate the growth rate of biomedical products, their import rate and suggest strategies to reach the specified horizon. Materials and Methods This research consists of two parts, quantitative and qualitative, in which the exploratory approach and the theorizing and typology model have been used. In the "quantitative" section, according to the country's pharmaceutical statistics, the growth trend of production and import of biopharmaceuticals over the past decade was calculated. The next step was performed "qualitatively" using the data research method of the grounded theory. First, information about the country's biopharmaceutical market was collected through interviews with 25 experts in this field. Then the "key templates" became the appropriate model. Results The results of the present study in the qualitative section were the extraction more than 326 open codes which is presented in the form of a paradigm model. In the quantitative sector, Iran's global share was estimated at 0.5% to 0.7%, which is growing with an average numerical growth of 5.6% and 30% in Rial. The average global market growth was estimated at 8.2% per year. Conclusion Considering Iran's 0.5% share of the world market, with the continuation of the current trend, it is not possible to achieve the set horizon and to achieve this horizon, we need a leap in pharmaceutical biotechnology.Tabatabaian SH, Tahoori H, Taqwa M, Taqvi Fard SM. Biomedical Innovation Ecosystem Analysis in Iran. Technology Development Management Quarterly, 1397; 6 (1): 9-45. doi: 10.22104/jtdm.2018.2582.1874. https://civilica.com/doc/896209/
Rastegar H, Taherian M. Best pharmaceutical and medical technologies perspectives to 2050. 1st ed. Royan pazhouh publication. 1398; P.19-20.
Kheirandish A, Zargham N. History and function of the biotechnology commiossion of the scientific research council of the country. Rahyarf, 1381; 12 (28): 5-20.
Saberi F, Babaei D, Malmir S, Musazadeh Moghadam M, Mirnejad R. Investigating the commercial position and sales of biotechnology pharmaceutical products. Molecular cell biotechnology news. 1394; 5 (20): 9-21.
Moorkens et al. Biopharmaceutical medicines: A snapshot of a diverse industerial landscape. Frontiers in pharmacology. 2017. 8 (12): 7-10. Doi:10.3389/fphar.2017.00314
Zohur A, Karimi Monghi H. Information analysis in qualitative studies. Principles of mental health. 1382 [cited 2022February03]; 5 (20-19): 107-113.
Zohur A, Karimi Monghi H. Information analysis in qualitative studies. Scientific Journal of Birjand University of Medical Sciences. 1382 [cited 2022February03]; 10 (3 (17 consecutive)): 10-14. Available from: https://www.sid.ir/fa/journal/ViewPaper.aspx?id=25422
http://amarname.com/
https://www.statista.com/statistics/825698/cost-to-bring-large-cap-biopharmaceutical-assets-to-market/
Juliet M, corbin. Basics of qualitative research: techniques and procedures for developing grounded theory. 3th ed. Andishe rafi. 1391; P 20-53.
Bell W, Foundations of futures studies history, purposes and knowledge. 4th ed. Defense industries research and training institute. 1398; P 40-52.
Abbaszadeh M. Reflections on the validity and reliability of qualitative research. Journal of Humanities Research, University of Isfahan. 1391; 23 (45): 19-34.
Files | ||
Issue | Vol 9 No 3 (2023) | |
Section | Original Article(s) | |
DOI | https://doi.org/10.18502/jppm.v9i3.14190 | |
Keywords | ||
biopharmaceuticals import horizon 1404 coding grounded theory |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |